[Today's focus]

Pharmaceutical Biology (02269.HK): 132 new projects were added in 2023, bringing the total number of projects to 698

Pharmaceutical Biotech (02269.HK) announced that the company will attend the 42nd Annual J.P. Morgan Healthcare Conference (“Annual Healthcare Conference”) on January 11, 20241 (Hong Kong time). At the conference, a briefing containing certain information on the company's business operations (“Briefing”) will be given. To ensure that all shareholders and potential investors of the Company can obtain such information in a fair and timely manner, the Company included the full text of the briefing in the announcement. Shareholders and potential investors of the Company should note that the briefing may contain forward-looking statements, which by their nature are risky and uncertain, and that any estimates and future recommendations stated in the briefing are based on certain assumptions and estimates and management's judgment based solely on currently available information.

As revealed in the briefing, the company's business and financial situation is still strong. 132 new projects were added in 2023, bringing the total number of projects to 698 (including 9 Phase III and commercial “winners” projects, and 24 CMO projects). These projects have verified the customer's trust and recognition of the company's CMO capabilities and scale, and the increase in the number of CMO projects will further enhance the company's recent earnings. Through a “follower” strategy and improving the ability to establish multiple technology platforms to enable multiple technologies, the company is confident that it will continue to achieve steady growth in 2024 and is confident about the future.

[Important matters]

A subsidiary of Yihe Holdings (01662.HK) signed a framework agreement with the Hong Kong University of Science and Technology

Shangao New Energy (01250.HK) Joint Venture Approved Jiangsu 100MW Market-Connected Project Index

Century Joint Holdings (01959.HK): Will develop in-depth cooperation with Xiaoju New Energy in the field of new energy vehicle charging service systems and operation and construction

Shanghai Fudan (01385.HK): Company shares held by Shanghai Government and its co-actors are all in a state of judicial freeze/judicial marking

[Financial performance]

Sa Sa International (00178.HK): Third quarter turnover increased 36.7% year-on-year to HK$1,182 billion

[Operation Data]

Shimao Group (00813.HK)'s total cumulative contract sales for 2023 is about 42.82 billion yuan

The cumulative sales amount of Yuzhou Group (01628.HK) in 2023 was 17.836 billion yuan

Hong Kong Dragon China Land (06968.HK): Achieved a total contract sales amount of 12.2 billion yuan in 2023

Baosheng International (03813.HK): Comprehensive cumulative net operating income of RMB 20.064 billion in 2023 increased 7.7% year-on-year

CGN New Energy (01811.HK): Cumulative completed power generation capacity of 19076.6 GWH in 2023 decreased by 0.6% year-on-year

Zhongyuan Construction (09982.HK) added a new contract construction area of 7.155 million square meters in 2023, an increase of 112.5% year-on-year

Yuexiu Transport Infrastructure (01052.HK): Humen Bridge toll revenue of 88.01 million yuan in November increased 65.1% year-on-year

COFCO Jiajiakang (01610.HK) Operation Report: 753,000 pigs released in December

Yuyuan Group (00551.HK): Net consolidated cumulative operating income of US$7.89 billion in 2023 decreased by 12.04% year-on-year

[Pharmaceutical Innovation]

Fosun Pharmaceutical (02196.HK): Famotidine injection drug registration application accepted

[Acquisition and sale]

Dexiang Real Estate (00199.HK) plans to sell 49% of Premier Maker's shares for HK$50 million

Han Guo Real Estate (00160.HK): The Bauhinia Hotels Group Japan 3 plans to acquire Japanese properties for about HK$42.39 million

Enterprise Exhibition Holdings (01808.HK) purchased a total of 7,207 NVDA shares

[Increase or decrease holdings]

Yadi Holdings (01585.HK) received a total increase of 290,000 shares by the controlling shareholder

[Repurchase Cancellation]

Tencent Holdings (00700.HK) spent HK$502 million to buy back 1.79 million shares on January 10

Meituan-W (03690.HK) spent HK$400 million to buy back 5.63 million shares on January 10

HSBC Holdings (00005.HK) spent HK$210 million to repurchase 3.298,000 shares on January 9

AIA (01299.HK) spent HK$135 million to buy back 2.16 million shares on January 10

Xiaomi Group-W (01810.HK) spent HK$49.14 million to buy back 3.5 million shares on January 10

Shell-W (02423.HK) spent 5 million US dollars to buy back 1.01 million shares on January 9

COSCO Maritime Holdings (01919.HK) spent HK$20.35 million to repurchase 2.66 million shares on January 10

ESR (01821.HK) spent HK$17.269,000 to buy back 1,586,800 shares on January 10

Kingdee International (00268.HK) spent HK$12.872,800 to buy back 1.287 million shares on January 10

Prudential (02378.HK) spent £2.784 million to buy back 330,000 shares on January 9

Yum China (09987.HK) spent 2.4 million US dollars to buy back 61,000 shares on January 9

Jinshan Software (03888.HK) spent HK$9.999 million to buy back 458,600 shares on January 10

Conch Cement (00914.HK) spent 7.858,600 yuan to buy back 350,000 A shares on January 10

Haier Smart Home (06690.HK) spent 7.55 million yuan to buy back 352,000 A shares on January 10

Wanwuyun (02602.HK) spent HK$4.7797 million to repurchase 229,300 shares on January 10

Huiliang Technology (01860.HK) spent HK$4.266,800 to buy back 1.489 million shares on January 10

Deutsche Bank World (02418.HK) spent HK$3.9 million to buy back 2 million shares on January 10

Zhihu-W (02390.HK) spent 492,100 US dollars to buy back 278,300 shares on January 9

Skyworth Group (00751.HK) spent HK$3.8749 million to repurchase 1.3 million shares on January 10

SF Express Tongcheng (09699.HK) spent HK$3,328,800 to repurchase 300,000 shares on January 10

Beijing Holdings Urban Resources (03718.HK) spent HK$3.0217 million to buy back 5.5 million shares on January 10